100

Bioinformatics of the Brain

[53] J. Jablonska, S. Leschner, and K. Westphal et al., “Neutrophils respon-

sive to endogenous IFN-β regulate tumor angiogenesis and growth in a

mouse tumor model,” The Journal of Clinical Investigation, vol. 120,

no. 4, pp. 1151–1164, 2010.

[54] I. Ozel, I. Duerig, and M. Domnich et al., “The good, the bad, and

the ugly: neutrophils, angiogenesis, and cancer,” Cancers, vol. 14, no. 3,

p. 536, 2022.

[55] A. J. Sedgwick, N. Ghazanfari, and P. Constantinescu et al., “The role

of NK cells and innate lymphoid cells in brain cancer,” Frontiers in

Immunology, vol. 11, p. 1549, 2020.

[56] M. Wang, Z. Zhou, and X. Wang et al., “Natural killer cell awaken-

ing: unleash cancer-immunity cycle against glioblastoma,” Cell Death &

Disease, vol. 13, no. 7, p. 588, 2022.

[57] P. Roth, M. Mittelbronn, and W. Wick et al., “Malignant glioma cells

counteract antitumor immune responses through expression of lectin-like

transcript-1,” Cancer Research, vol. 67, no. 8, pp. 3540–3544, 2007.

[58] U. Johansson, L. Walther-Jallow, and A. Hofmann et al., “Dendritic

cells are able to produce IL-12p70 after uptake of apoptotic cells,” Im-

munobiology, vol. 216, no. 1, pp. 251–255, 2011.

[59] A. Karachi, F. Dastmalchi, and S. Nazarian et al., “Optimizing T

cell-based therapy for glioblastoma,” Frontiers in Immunology, vol. 12,

p. 705580, 2021.

[60] J. Dörr, S. Waiczies, and U. Wendling et al., “Induction of TRAIL-

mediated glioma cell death by human T cells,” Journal of Neuroim-

munology, vol. 122, no. 1-2, pp. 117–124, 2002.

[61] M. Tekguc, J. B. Wing, and M. Osaki et al., “Treg-expressed CTLA-4

depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-

presenting cells,” Proceedings of the National Academy of Sciences,

vol. 118, no. 30, p. e2023739118, 2021.

[62] H. Liang, L. Yi, and X. Wang et al., “Interleukin-17 facilitates the im-

mune suppressor capacity of high-grade glioma-derived CD4 (+) CD25

(+) Foxp3 (+) T cells via releasing transforming growth factor beta,”

Scandinavian Journal of Immunology, vol. 80, no. 2, pp. 144–150, 2014.

[63] S. Liu, C. Zhang, and B. Wang et al., “Regulatory T cells promote glioma

cell stemness through TGF-β–NF-κB–IL6–STAT3 signaling,” Cancer

Immunology, Immunotherapy, pp. 2601–2616, 2021.

[64] D. A. Thomas and J. Massagué, “TGF-β directly targets cytotoxic T cell

functions during tumor evasion of immune surveillance,” Cancer Cell,

vol. 8, no. 5, pp. 369–380, 2005.